ホーム › 過体重 › アラバマ州 › Birmingham
Birmingham、ALにおける過体重の臨床試験
Birminghamとその周辺地域（約30マイル以内）の拠点で、過体重に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
被験者募集中第3相
- Univ of Alabama Birmingham, Birmingham
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
被験者募集中第2相
- University of Alabama - Birmingham, Birmingham
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
被験者募集中第3相
- Univ of Alabama Birmingham, Birmingham
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
被験者募集中第3相
- Central Research Associates, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
被験者募集中第3相
- Birmingham Clinical Research, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
被験者募集中第3相
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
被験者募集中第3相
- AURORA-1 Clinical Site, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
被験者募集中第3相
- AURORA-2 Clinical Site, Birmingham
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
被験者募集中第3相
- Alabama Clinical Therapeutics, Birmingham
- University of Alabama at Birmingham, Birmingham
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
被験者募集中第3相健康なボランティア歓迎
- ACCOMPLISH-2 Research Site, Birmingham
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
被験者募集中第3相
- Uni of Alabama at Birmingham, Birmingham
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
被験者募集中第3相
- Kailera Clinical Site, Birmingham
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
被験者募集中第3相
- ACCOMPLISH-1 Research Site, Birmingham
- ACCOMPLISH-1 Research Site, Birmingham
Time-restricted Eating for Postpartum Weight Loss
被験者募集中
- University of Alabama at Birmingham, Birmingham
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
被験者募集中
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
被験者募集中
- The Worship Center Cristian Church, Birmingham
他の都市における過体重の試験
- San Antonio, TX34件の研究
- Houston, TX33件の研究
- Chicago, IL28件の研究
- Orlando, FL27件の研究
- Las Vegas, NV23件の研究
- Miami, FL23件の研究
- Atlanta, GA20件の研究
- Dallas, TX20件の研究
- New York City, NY19件の研究
- Jacksonville, FL19件の研究
- Washington, DC19件の研究
- Austin, TX18件の研究
Birminghamにおける他の研究
- がん（全種類）30件の研究
- 乳がん24件の研究
- 肥満症23件の研究
- 卵巣がん23件の研究
- 非小細胞肺癌22件の研究
- 急性骨髄性白血病21件の研究
- 多発性骨髄腫18件の研究
- COPD17件の研究
- 心血管疾患17件の研究
- 子宮内膜がん16件の研究
- 2型糖尿病16件の研究
- 嚢胞性線維症16件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。